Skip to main content
Top

Open Access 20-04-2024 | Methotrexate | Case Report

A case of methotrexate-related lymphoproliferative disease showing multiple liver lesions in a patient with rheumatoid arthritis

Authors: Yamato Nagata, Shotaro Akiba, Hidekazu Horiuchi, Kazuo Okumoto, Shigemi Hachinohe, Rintaro Ohe

Published in: Clinical Journal of Gastroenterology

Login to get access

Abstract

A 66-year-old woman with rheumatoid arthritis (RA) who had been receiving methotrexate (MTX) for 2 years presented with tarry stools. Contrast-enhanced computed tomography (CT) of the abdomen revealed irregular wall thickening in the ileocecal region and multiple low-contrast masses in both lobes of the liver. Lower gastrointestinal endoscopy revealed a type 2 tumor in the ileocecal region with a semi-peripheral ulcer. Histological examination of liver and colon biopsies showed other iatrogenic immunodeficiency-associated lymphoproliferative disorder (Oi-LPD), diffuse large B-cell lymphoma type, with positivity for Epstein-Barr virus DNA. After withdrawal of MTX, the LPD lesions disappeared and the patient achieved remission. We considered this to be a sporadic case of Oi-LPD, diffuse large B-cell lymphoma type, in the liver and colon due to treatment with MTX. There has been no previous report of this condition with simultaneous hepatic and colonic lesions, and the present case is thought to be highly informative in relation to the pathogenesis.
Literature
1.
go back to reference Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68:1–26.CrossRefPubMed Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68:1–26.CrossRefPubMed
2.
3.
go back to reference Saito S, Takeuchi T. Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients. J Clin Exp Hematop. 2019;59:145–55.CrossRefPubMedPubMedCentral Saito S, Takeuchi T. Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients. J Clin Exp Hematop. 2019;59:145–55.CrossRefPubMedPubMedCentral
4.
go back to reference Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009;125:398–405.CrossRefPubMedPubMedCentral Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009;125:398–405.CrossRefPubMedPubMedCentral
5.
go back to reference Katsuyama T, Sada KE, Yan M, et al. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents. Mod Rheumatol. 2017;27:773–7.CrossRefPubMed Katsuyama T, Sada KE, Yan M, et al. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents. Mod Rheumatol. 2017;27:773–7.CrossRefPubMed
6.
go back to reference Kikuchi K, Miyazaki Y, Tanaka A, et al. Methotrexate-related epstein-barr virus (EBV)-associated lymphoproliferative disorder–so-called “Hodgkin-like lesion”–of the oral cavity in a patient with rheumatoid arthritis. Head Neck Pathol. 2010;4:305–11.CrossRefPubMedPubMedCentral Kikuchi K, Miyazaki Y, Tanaka A, et al. Methotrexate-related epstein-barr virus (EBV)-associated lymphoproliferative disorder–so-called “Hodgkin-like lesion”–of the oral cavity in a patient with rheumatoid arthritis. Head Neck Pathol. 2010;4:305–11.CrossRefPubMedPubMedCentral
7.
go back to reference Kitamura N, Sugiyama K, Nagasawa Y, et al. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2022;40:1330–5.PubMed Kitamura N, Sugiyama K, Nagasawa Y, et al. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2022;40:1330–5.PubMed
8.
go back to reference Afonso C, Roque A, Almeida C, et al. Methotrexate-associated lymphoproliferative disorder in a patient with psoriasis: a case report and review of the literature. Case Rep Hematol. 2022;2022:7178065.PubMedPubMedCentral Afonso C, Roque A, Almeida C, et al. Methotrexate-associated lymphoproliferative disorder in a patient with psoriasis: a case report and review of the literature. Case Rep Hematol. 2022;2022:7178065.PubMedPubMedCentral
9.
go back to reference Grywalska E, Markowicz J, Grabarczyk P, et al. Epstein-Barr virus-associated lymphoproliferative disorders. Postepy Hig Med Dosw (Online). 2013;67:481–90.CrossRefPubMed Grywalska E, Markowicz J, Grabarczyk P, et al. Epstein-Barr virus-associated lymphoproliferative disorders. Postepy Hig Med Dosw (Online). 2013;67:481–90.CrossRefPubMed
10.
go back to reference Tsukazaki Y, Shinohara T, Tanaka K, et al. Hepatosplenic Hodgkin lymphoma without lymphadenopathy following reversible methotrexate-associated lymphoproliferative disorder. Mod Rheumatol. 2017;27:372–5.CrossRefPubMed Tsukazaki Y, Shinohara T, Tanaka K, et al. Hepatosplenic Hodgkin lymphoma without lymphadenopathy following reversible methotrexate-associated lymphoproliferative disorder. Mod Rheumatol. 2017;27:372–5.CrossRefPubMed
12.
go back to reference Hiruma M, Tsuboi K, Hirose T. Methotrexate-associated lymphoproliferative disorder in the thyroid gland of a patient with chronic thyroiditis. J Med Ultrason. 2001;2023(50):575–6. Hiruma M, Tsuboi K, Hirose T. Methotrexate-associated lymphoproliferative disorder in the thyroid gland of a patient with chronic thyroiditis. J Med Ultrason. 2001;2023(50):575–6.
13.
go back to reference Suemori K, Hasegawa H, Ishizaki J, et al. Methotrexate-associated lymphoproliferative disease with multiple pulmonary nodules in a patient with rheumatoid arthritis. Intern Med. 2015;54:1421–5.CrossRefPubMed Suemori K, Hasegawa H, Ishizaki J, et al. Methotrexate-associated lymphoproliferative disease with multiple pulmonary nodules in a patient with rheumatoid arthritis. Intern Med. 2015;54:1421–5.CrossRefPubMed
14.
go back to reference Omameuda T, Miyato H, Sata N, et al. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: a case report. Medicine (Baltimore). 2022;101: e31993.CrossRefPubMed Omameuda T, Miyato H, Sata N, et al. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: a case report. Medicine (Baltimore). 2022;101: e31993.CrossRefPubMed
16.
go back to reference Takasumi M, Okai K, Asano T, et al. A case of methotrexate-associated lymphoproliferative disorder diagnosed by liver biopsy. Nihon Shokakibyo Gakkai Zasshi. 2015;112(1):115–22.PubMed Takasumi M, Okai K, Asano T, et al. A case of methotrexate-associated lymphoproliferative disorder diagnosed by liver biopsy. Nihon Shokakibyo Gakkai Zasshi. 2015;112(1):115–22.PubMed
17.
go back to reference Soubrier M, Arrestier S, Bouloudian S, et al. Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis. Joint Bone Spine. 2006;73:218–9.CrossRefPubMed Soubrier M, Arrestier S, Bouloudian S, et al. Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis. Joint Bone Spine. 2006;73:218–9.CrossRefPubMed
18.
go back to reference Fujita T, Tanabe M, Iida E, et al. Multi-modality imaging findings of methotrexate-related Epstein-Barr virus-associated hepatic tumor. Clin Imaging. 2013;37:962–4.CrossRefPubMed Fujita T, Tanabe M, Iida E, et al. Multi-modality imaging findings of methotrexate-related Epstein-Barr virus-associated hepatic tumor. Clin Imaging. 2013;37:962–4.CrossRefPubMed
19.
go back to reference Tatsumi G, Ukyo N, Hirata H, et al. Primary hepatic lymphoma in a patient with rheumatoid arthritis treated with methotrexate. Case Rep Hematol. 2014;2014: 460574.PubMedPubMedCentral Tatsumi G, Ukyo N, Hirata H, et al. Primary hepatic lymphoma in a patient with rheumatoid arthritis treated with methotrexate. Case Rep Hematol. 2014;2014: 460574.PubMedPubMedCentral
20.
go back to reference Kawahara A, Tsukada J, Yamaguchi T, et al. Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma. Biomark Res. 2015;3:10.CrossRefPubMedPubMedCentral Kawahara A, Tsukada J, Yamaguchi T, et al. Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma. Biomark Res. 2015;3:10.CrossRefPubMedPubMedCentral
21.
go back to reference Miyagawa K, Shibata M, Noguchi H, et al. Methotrexate-related primary hepatic lymphoma in a patient with rheumatoid arthritis. Intern Med. 2015;54:401–5.CrossRefPubMed Miyagawa K, Shibata M, Noguchi H, et al. Methotrexate-related primary hepatic lymphoma in a patient with rheumatoid arthritis. Intern Med. 2015;54:401–5.CrossRefPubMed
22.
go back to reference Ohkura Y, Shindoh J, Haruta S, et al. Primary adrenal lymphoma possibly associated with Epstein-Barr virus reactivation due to immunosuppression under methotrexate therapy. Medicine (Baltimore). 2015;94: e1270.CrossRefPubMed Ohkura Y, Shindoh J, Haruta S, et al. Primary adrenal lymphoma possibly associated with Epstein-Barr virus reactivation due to immunosuppression under methotrexate therapy. Medicine (Baltimore). 2015;94: e1270.CrossRefPubMed
23.
go back to reference Matsumoto R, Numata K, Doba N, et al. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder. J Med Ultrason. 2001;2016(43):545–51. Matsumoto R, Numata K, Doba N, et al. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder. J Med Ultrason. 2001;2016(43):545–51.
24.
go back to reference Takei D, Abe T, Amano H, et al. Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: a case report. Int J Surg Case Rep. 2017;31:5–9.CrossRefPubMed Takei D, Abe T, Amano H, et al. Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: a case report. Int J Surg Case Rep. 2017;31:5–9.CrossRefPubMed
25.
go back to reference Ono R, Kumagae T, Uojima H, et al. Hepatic methotrexate-associated lymphoproliferative disorders identified by multiple liver tumors: a case report and review of the literature. J Med Case Rep. 2019;13:196.CrossRefPubMedPubMedCentral Ono R, Kumagae T, Uojima H, et al. Hepatic methotrexate-associated lymphoproliferative disorders identified by multiple liver tumors: a case report and review of the literature. J Med Case Rep. 2019;13:196.CrossRefPubMedPubMedCentral
26.
go back to reference Ito N, Masuda T, Yamaguchi K, et al. Pneumonia and meningoencephalitis due to varicella-zoster virus reinfection and Epstein-Barr virus reactivation in a patient with rheumatoid arthritis. Intern Med. 2022;61:2961–5.CrossRefPubMedPubMedCentral Ito N, Masuda T, Yamaguchi K, et al. Pneumonia and meningoencephalitis due to varicella-zoster virus reinfection and Epstein-Barr virus reactivation in a patient with rheumatoid arthritis. Intern Med. 2022;61:2961–5.CrossRefPubMedPubMedCentral
Metadata
Title
A case of methotrexate-related lymphoproliferative disease showing multiple liver lesions in a patient with rheumatoid arthritis
Authors
Yamato Nagata
Shotaro Akiba
Hidekazu Horiuchi
Kazuo Okumoto
Shigemi Hachinohe
Rintaro Ohe
Publication date
20-04-2024
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.